Publications

Improved tumor cell invasiveness measurement using digital holographic microscopy

Improved tumor cell invasiveness measurement using digital holographic microscopy

Optical Cellular Micromotion: A new paradigm to measure tumor cells Invasion within gels mimicking the 3D tumor environments.
Guo Z, Yang CT, Chien CC, Selth LA, Bagnaninchi PO, Thierry B. Small Methods. 2022 Jun 28:e2200471. doi: 10.1002/smtd.202200471.
Contact: Luke Selth

Level playing field: young males, masculinity and mental wellbeing through sport

Level playing field: young males, masculinity and mental wellbeing through sport

Level playing field: young males, masculinity and mental wellbeing through sport.
Drummond, M., Wadham, B., Prichard, I. et al. BMC Public Health 22, 756 (2022). https://doi.org/10.1186/s12889-022-13200-1.
Contact: Murray Drummond

Validation of a short form Male Depression Risk Scale

Validation of a short form Male Depression Risk Scale

Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men. Herreen D, Rice S, Zajac I. Brief assessment of male depression in clinical care:BMJ Open. 2022 Mar 28;12(3):e053650. doi: 10.1136/bmjopen-2021-053650.

Contact: Dr Ian Zajac

Reviewing spatial approaches to target identification and treatment decision-making for prostate cancer.

Reviewing spatial approaches to target identification and treatment decision-making for prostate cancer.

Unravelling Prostate Cancer Heterogeneity Using Spatial Approaches to Lipidomics and Transcriptomics. Cancers. Mutuku SM, Spotbeen X, Trim PJ, Snel MF, Butler LM, Swinnen JV. (Basel). 2022 Mar 27;14(7):1702. doi: 10.3390/cancers14071702.

Contact: Lisa Butler

Using Patient-Derived Explants in Prostate Cancer Research

Using Patient-Derived Explants in Prostate Cancer Research

Harnessing the Heterogeneity of Prostate Cancer for Target Discovery Using Patient-Derived Explants. Centenera MM, Vincent AD, Moldovan M, Lin HM, Lynn DJ, Horvath LG, Butler LM. Cancers (Basel). 2022 Mar 28;14(7):1708. doi: 10.3390/cancers14071708.

Contact: Lisa Butler

Adherence to secondary prevention for patients with cardiovascular disease and mental health disorders

Adherence to secondary prevention for patients with cardiovascular disease and mental health disorders

Understandings and experiences of adherence to secondary prevention for patients with cardiovascular disease and comorbid depression or anxiety. Cosh SM, Pinto R, Denson L, Tully PJ Psychol Health Med. 2022 Mar 31:1-8. doi: 10.1080/13548506.2022.2060515. Epub ahead of print. PMID: 35356823.
Contact: Phillip Tully

Geneotypes of men with advanced prostate cancer who may benefit from metabolic therapies

Geneotypes of men with advanced prostate cancer who may benefit from metabolic therapies

Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer. Mak B, Lin HM, Kwan EM, Fettke H, Tran B, Davis ID, Mahon K, Stockler MR, Briscoe K, Marx G, Zhang A, Crumbaker M, Tan W, Huynh K, Meikle TG, Mellett NA, Hoy AJ, Du P, Yu J, Jia S, Joshua AM, Waugh DJ, Butler LM, Kohli M, Meikle PJ, Azad AA, Horvath LG. BMC Med. 2022 Mar 25;20(1):112. doi: 10.1186/s12916-022-02298-0.
Contact: Lisa Butler

Identifying the most appropriate bone scan strategy for Australian men with prostate cancer

Identifying the most appropriate bone scan strategy for Australian men with prostate cancer

Evaluation of selective bone scan staging in prostate cancer - external validation of current strategies and decision-curve analysis.

Hiwase MD, Jay A, Bulamu N, Teh J, Paterson F, Kichenadasse G, Vincent AD, O'Callaghan M; South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC). Prostate Cancer Prostatic Dis. 2022 Mar 14. doi: 10.1038/s41391-022-00515-8.


Contact: Andrew Vincent

Long term toxicity following radiotherapy for prostate cancer - A review

Long term toxicity following radiotherapy for prostate cancer - A review

Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis.

David R, Buckby A, Kahokehr AA, Lee J, Watson DI, Leung J, O'Callaghan ME. Prostate Cancer Prostatic Dis. 2022 Mar 8. doi: 10.1038/s41391-022-00520-x.
Contact: Michael O’Callaghan

"She'll Be Right, Mate": A Mixed Methods Analysis of Skin Cancer Prevention Practices among Australian Farmers-An At-Risk Group

"She'll Be Right, Mate": A Mixed Methods Analysis of Skin Cancer Prevention Practices among Australian Farmers-An At-Risk Group

"She'll Be Right, Mate": A Mixed Methods Analysis of Skin Cancer Prevention Practices among Australian Farmers-An At-Risk Group. Trenerry C, Fletcher C, Wilson C, Gunn K. Int J Environ Res Public Health. 2022 Mar 3;19(5):2940. doi: 10.3390/ijerph19052940.


Contact: Kate Gunn

Testosterone, Diabetes Risk, and Diabetes Prevention in Men

Testosterone, Diabetes Risk, and Diabetes Prevention in Men

Testosterone, Diabetes Risk, and Diabetes Prevention in Men. Yeap BB, Wittert GA. Endocrinol Metab Clin North Am. 2022 Mar;51(1):157-172. doi: 10.1016/j.ecl.2021.11.004. Epub 2022 Feb 8. PMID: 35216714.
Contact: Gary Wittert

The association between sleep microarchitecture and cognitive function in middle-aged and older men: a community-based cohort study

The association between sleep microarchitecture and cognitive function in middle-aged and older men: a community-based cohort study

The association between sleep microarchitecture and cognitive function in middle-aged and older men: a community-based cohort study. Parker JL, Appleton SL, Melaku YA, D'Rozario AL, Wittert GA, Martin SA, Toson B, Catcheside PG, Lechat B, Teare AJ, Adams RJ, Vakulin A. J Clin Sleep Med. 2022 Feb 17. doi: 10.5664/jcsm.9934.

Contact: Jesse Parker